Drug Approval | February 26, 2024
Concord Biotech receives GMP certificate from Kenya regulator
The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series
The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series
The observations do not pose any risk to site's compliance standards or its business continuity
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
The acquisition enriches AstraZeneca’s growing pipeline of cell therapies with GC012F
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
These digital avenues have not only revolutionized patient care but also opened up new opportunities for HCPs to build thought leadership in their respective fields
The acquisition will build on AstraZeneca’s expertise in respiratory syncytial virus
The launch of a DGCA Type Approved Logistics Drone facilitates critical medical deliveries to remote regions
Subscribe To Our Newsletter & Stay Updated
